[Drug therapy at the beginning of the genomic era].

Abstract excerpt

The individualisation of drug therapy according to the genetic profile of each patient would allow to avoid the adverse effects and to reach the maximum therapeutic efficiency, therefore an optimum risk/efficiency ratio. This desideratum has become feasible in the genomic era by identifying and mapping a true mononucleotid polymorphism signature DNA (single nucleotide polymorphism fingerprint--SNP) and by using...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Therapy
• Share to Genomics
• Share to Pharmacogenetics